FibroGen (FGEN) Stock Price
$0.706 0%
to add to portfolio
AI Score
-
Alternative
2 -
Fundamental
1 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on FibroGen, AI stock picks, stock alerts and much more.
FGEN AI Stock Analysis
AI stock analysis for FGEN is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like FibroGen (FGEN) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
FibroGen (FGEN) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of FibroGen (FGEN), currently trading at $0.706, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About FGEN
-
FibroGen, Inc.
-
Symbol
FGEN
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
71.1M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
FGEN Alternative Data
Web Traffic
FibroGen receives an estimated 6127 monthly visitors to fibrogen.com.
-
Web Traffic
6127
-
Change from Previous Month
9%
-
3 Month Change
11.2%
-
YoY Change
11.2%
News Mentions
FibroGen was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
FibroGen has been mentioned an estimated 7 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
7
-
Daily Change
84.8%
Twitter Followers
FibroGen has 998 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.5% over the last month.
-
Twitter Followers
998
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
1.2%
LinkedIn Followers
16,626 are following FibroGen on LinkedIn, up by 0.5% over the last month.
-
LinkedIn Followers
16626
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
1.1%
Job Postings
FibroGen currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, FibroGen has 331 employees, down by -1.2% over the last month.
-
LinkedIn Employees
331
-
Daily Change
0.3%
-
1 Month Change
1.2%
-
3 Month Change
10.5%
Business Outlook
-
Business Outlook
45
-
Change from Previous Month
4.7%
-
3 Month Change
0%
-
YoY Change
0%
FGEN Financials
FGEN Key Metrics
-
Total Revenue
$46.3M
-
Net Income
-$17.1M
-
Earnings per Share
-$0.17
-
Free cash flow
-$8.5M
-
EBITDA
-$12.2M
-
EBITDA Ratio
-0.26411
-
Total Assets
$264.4M
FGEN 2-year Revenue & Income
FGEN 2-year Free Cash Flow
FGEN Technicals
FGEN SMA
FGEN RSI
FAQ
What's the current price of FibroGen (FGEN) Stock?
The price of an FibroGen (FGEN) share is $0.706.
What's the market cap of FibroGen?
The current market cap of FibroGen is 71.1M.
Should I buy or sell FGEN?
FibroGen exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is FibroGen a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in FibroGen stock. There are several bearish signals and market challenges that could negatively impact FibroGen's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy FibroGen (FGEN) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy FibroGen stock right now, as the outlook appears bearish.
What are some stocks similar to FibroGen (FGEN) that investors often compare it to?
FibroGen (FGEN) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for FibroGen's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast FibroGen's stock price to be around $0.639 in 2026. Starting from the current price of $0.706, this represents a 9.5% change in price, indicating a bearish outlook for the stock.
How to buy FibroGen (FGEN) Stock?
FibroGen stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy FibroGen shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.